Editas Medicine to Present at the Bank of America Merrill Lynch 2018 Health Care Conference – Nasdaq
|
Editas Medicine to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
Nasdaq As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the … |
